Sales Methodology Selection Decision Tree
A branching decision tree that turns deal size, buying-committee size, sales-cycle length, and market maturity into a recommended methodology or blend.
What's inside
- Full branching decision tree keyed on ACV, stakeholder count, cycle length, and market maturity
- The two-axis model explaining why every branch resolves to a qualification layer plus a conversation layer
- Numeric scoring matrix with 4 weighted dimensions
- Score-to-zone mapping table
- Named blend table with 'use when' triggers for each combination
Answer four questions about your motion. Get a starting methodology (or blend) — not a religious commitment, a starting point to test.
The tree
`` START │ ├─ Q1: Average deal size (ACV)? │ ├── Under $10k │ └─ Q2: Sales cycle under 30 days AND 1–2 stakeholders? │ ├── YES → SANDLER (fast disqualification, objection handling, minimal process overhead) │ └── NO → SPIN + light MEDDIC (Metrics + Champion only) │ ├── $10k–$50k │ └─ Q2: 2–4 stakeholders, cycle 1–3 months? │ ├── YES → SPIN (discovery technique) + MEDDIC-lite (Metrics, Economic Buyer, Champion) │ └── NO, fewer stakeholders/shorter cycle → SANDLER │ ├── $50k–$250k │ └─ Q2: 3–6 stakeholders, cycle 3–9 months? │ ├── YES, and market is crowded/commoditized → CHALLENGER (Teach/Tailor) + full MEDDIC │ └── YES, but market is novel/uneducated → SPIN-led discovery + full MEDDIC │ └── $250k+ └─ Q2: 5+ stakeholders, cycle 9+ months, procurement/security/legal review expected? ├── YES → MEDDPICC + COMMAND OF THE MESSAGE └── Public sector / formal RFP → MEDDPICC (Paper Process is non-negotiable), regardless of size ``
The two axes underneath the tree
Every branch above is really answering two independent questions:
- How real is this deal, and will it survive procurement? → answered by the qualification layer: MEDDIC → MEDDPICC as stakeholders, cycle length, and procurement rigor increase.
- How do we actually run the conversation and differentiate? → answered by the conversation layer: SPIN → Challenger → Command of the Message as market crowding and rep-population scale increase, with Sandler as the alternative when speed/disqualification matters more than insight-selling.
You always pick one from each axis. The tree above just tells you where to start on each.
Scoring matrix (if your motion doesn't fit neatly into one branch)
Score each dimension, sum, and match to a zone.
| Dimension | 1 point | 2 points | 3 points | 4 points |
|---|---|---|---|---|
| Deal size (ACV) | <$10k | $10k–$50k | $50k–$250k | $250k+ |
| Buying committee size | 1 | 2–4 | 5–7 | 8+ |
| Sales cycle length | <30 days | 1–3 months | 3–9 months | 9+ months |
| Market maturity | — | Crowded/commoditized (2) | Novel/uneducated (2) | — |
(Market maturity is scored 2 either way — it doesn't change the qualification layer, only which conversation layer you pick: crowded → Challenger-leaning, novel → SPIN-leaning.)
| Total score | Zone | Recommended stack |
|---|---|---|
| 3–5 | High-velocity | Sandler |
| 6–8 | Mid-market | SPIN + MEDDIC-lite |
| 9–11 | Complex B2B | Challenger + MEDDIC (or SPIN + MEDDIC if market is novel) |
| 12–14 | Enterprise | MEDDPICC + Command of the Message |
Common blends, named
| Blend | Use when |
|---|---|
| MEDDIC + SPIN | Mid-market, buyer hasn't self-diagnosed the problem yet |
| MEDDIC + Challenger | Competitive, crowded market, buyer already knows the category |
| MEDDPICC + Command of the Message | Enterprise, PE-backed scaling org, message consistency across a large rep population matters |
| Sandler standalone | High-velocity SMB, price objections and stalling ("let me think about it") are the main obstacle |
| MEDDPICC + Sandler objection tactics | Enterprise deal that's stalling on late-stage buyer indecision rather than a qualification gap |
How to use it
Walk your motion through the tree top to bottom, or use the numeric scoring matrix if your deals don't fit one branch cleanly, then check the named-blend table for how to combine a qualification layer with a conversation layer.